Time matters: chrono-pharmacotherapy as precision medicine

The circadian clock and its inherent rhythms serve as the foundation for regulating many of the body’s vital processes. Recent advances in medicine have leveraged these natural cycles through chronotherapy, the practice of timing drug administration to align with the body's internal clock, to enhance treatment outcomes. Endogenous clocks not only dictate physiological rhythms but also influence how drugs are absorbed, distributed, metabolized, and excreted, thereby affecting both their therapeutic efficacy and potential toxicity. When these circadian rhythms are disrupted, the resulting imbalance has been linked to a range of disorders, such as cancer and cardiovascular diseases, highlighting the growing need for time-sensitive therapeutic strategies. Technological breakthroughs, including wearable sensors, digital health platforms, and sophisticated machine learning techniques, now allow for continuous, real-time monitoring of circadian biomarkers, which in turn helps optimize treatment regimens. In oncology, for example, synchronizing chemotherapy, cardiovascular therapy, immunotherapy and anti-inflammatory drugs with the patient’s circadian cycle has been shown to enhance drug effectiveness and improve tolerability. Moreover, observed sex-based differences in circadian drug responses emphasize the importance of tailoring drugs to individual patient profiles. Emerging research is also focusing on directly targeting molecular clock components, showing potential for treating metabolic and oncological conditions. However, fully integrating chronopharmacology into clinical practice will require the development of standardized protocols, regulatory backing, and large-scale trials that incorporate circadian biomarkers. Ultimately, merging circadian biology with therapeutic strategies promises to optimize treatment efficacy, minimize side effects, and enhance patient outcomes. Future studies must address inter-individual variability, sex differences, and circadian misalignment to fully harness chronotherapy’s potential in personalized medicine.

Authors

Institutions

Publication Details

Journal
Asia-Pacific Journal of Pharmacotherapy & Toxicology
Published
2025-02-20
DOI
https://doi.org/10.32948/ajpt.2025.01.20
Primary Topic
Circadian rhythm and melatonin
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Time matters: chrono-pharmacotherapy as precision medicine

Sajjad Ahmad, Samir Arabi
Asia-Pacific Journal of Pharmacotherapy & Toxicology
Circadian rhythm and melatonin
article

Time matters: chrono-pharmacotherapy as precision medicine

Sajjad Ahmad, Samir Arabi
article en

Abstract

The circadian clock and its inherent rhythms serve as the foundation for regulating many of the body’s vital processes. Recent advances in medicine have leveraged these natural cycles through chronotherapy, the practice of timing drug administration to align with the body's internal clock, to enhance treatment outcomes. Endogenous clocks not only dictate physiological rhythms but also influence how drugs are absorbed, distributed, metabolized, and excreted, thereby affecting both their therapeutic efficacy and potential toxicity. When these circadian rhythms are disrupted, the resulting imbalance has been linked to a range of disorders, such as cancer and cardiovascular diseases, highlighting the growing need for time-sensitive therapeutic strategies. Technological breakthroughs, including wearable sensors, digital health platforms, and sophisticated machine learning techniques, now allow for continuous, real-time monitoring of circadian biomarkers, which in turn helps optimize treatment regimens. In oncology, for example, synchronizing chemotherapy, cardiovascular therapy, immunotherapy and anti-inflammatory drugs with the patient’s circadian cycle has been shown to enhance drug effectiveness and improve tolerability. Moreover, observed sex-based differences in circadian drug responses emphasize the importance of tailoring drugs to individual patient profiles. Emerging research is also focusing on directly targeting molecular clock components, showing potential for treating metabolic and oncological conditions. However, fully integrating chronopharmacology into clinical practice will require the development of standardized protocols, regulatory backing, and large-scale trials that incorporate circadian biomarkers. Ultimately, merging circadian biology with therapeutic strategies promises to optimize treatment efficacy, minimize side effects, and enhance patient outcomes. Future studies must address inter-individual variability, sex differences, and circadian misalignment to fully harness chronotherapy’s potential in personalized medicine.

Asia-Pacific Journal of Pharmacotherapy & Toxicology
Islamic Azad University Islamshahr Branch (IR)
Openalex Percentile: Top 97%
Circadian rhythm and melatonin
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Time matters: chrono-pharmacotherapy as precision medicine — Sajjad Ahmad, Samir Arabi · Asia-Pacific Journal of Pharmacotherapy & Toxicology (2025) | TGRS Research Map | TGRS